findmyKOL

Robert Bhisitkul, MD

Enriched profile

Professor of Clinical Ophthalmology, Alex Irvine MD Endowed Chair; Director, Retina Fellowship, UCSF Department of Ophthalmology · University of California, San Francisco

ORCIDNPI
Region🇺🇸 San Francisco, CA · West · United StatesSpecialtyOphthalmologyFocusDiabetic Retinopathy / DME+1
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Robert Bhisitkul is Professor of Clinical Ophthalmology, Alex Irvine MD Endowed Chair; Director, Retina Fellowship, UCSF Department of Ophthalmology at University of California, San Francisco. OpenAlex indexes 87 publications with 4,434 citations (h-index 28); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Robert Bhisitkul, MD, is Professor of Clinical Ophthalmology, Alex Irvine MD Endowed Chair at University of California, San Francisco -- Department of Ophthalmology. The public record shows 87 publications with 4,434 citations (h-index 28), centered on Diabetic Retinopathy / DME, Glaucoma. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 10 companies.

  • Most recent indexed publication: 2024 · The British journal of ophthalmology
  • Top research focus: Diabetic Retinopathy / DME
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)1 trialDiabetic Complications1 trialDiabetic Retinopathy / DME1 trialDiabetic Retinopathy1 trialEdema1 trialMacular Edema1 trialRetinal Diseases1 trialGlaucoma1 trialComa1 trial

Research focus

OpenAlex concept fingerprint
Diabetic Retinopathy / DMEGlaucoma

Drugs & molecules

across trials, industry payments and publications
Eyleageneric · AfliberceptClinical trialsIndustry payments3PublicationsEYLEA HDClinical trialsIndustry payments3PublicationsTriesencegeneric · TriamcinoloneClinical trialsIndustry payments3Publications

Works with

trial sponsors and companies reporting payments
Alcon Vision LLCClinical trialsIndustry payments6Regeneron Healthcare Solutions, Inc.Clinical trialsIndustry payments6Genentech USA, Inc.Clinical trialsIndustry payments3

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
87publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

4,434citations

Total citations across indexed works.

28h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    100%
    Prostaglandin Analog44%
    Latanoprost100%
    Part D16 patients
    Carbonic Anhydrase Inhibitor19.8%
    Dorzolamide-Timolol100%
    Part D12 patients
Where care is delivered (Part B)62.8% facility · 37.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/robert-bhisitkul-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/robert-bhisitkul-0085644

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/scientific-contributions/Robert-B-Bhisitkul-58134170

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    asrs.org/find-a-specialist/profile/1464/Robert-B-Bhisitkul

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org
  • Other

    ibiology.org/ibiology_podcasts/tejal-desai-robert-bhisitkul-advancing-the-treatment-of-retinal-diseases

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ibiology.org
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Vitreo-retinal Surgery Fellowship

    Massachusetts Eye and Ear Infirmary / Harvard Medical School

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org
  • Ophthalmology Residency

    Massachusetts Eye and Ear Infirmary / Harvard Medical School

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org
  • MD

    Stanford University School of Medicine

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org
  • PhD in Neurosciences

    Yale University

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org
  • Board Certified

    American Board of Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ucsfhealth.org

Editorial & leadership roles

journal and society appointments
3 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • iBiology video talk with Tejal Desai

    "Advancing the Treatment of Retinal Diseases"

    2014
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ibiology.org
  • YouTube video

    "Oculinea - Robert Bhisitkul, MD, PhD"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.